Osteoblast-specific overexpression of human WNT16 increases both cortical and trabecular bone mass and structure in mice

Imranul Alam, Mohammed Alkhouli, Rita L. Gerard-O'Riley, Weston B. Wright, Dena Acton, Amie K. Gray, Bhavmik Patel, Austin M. Reilly, Kyung Eun Lim, Alexander Robling, Michael Econs

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Previous genome-wide association studies have identified common variants in genes associated with bone mineral density (BMD) and risk of fracture. Recently, we identified single nucleotide polymorphisms (SNPs) in Wingless-type mouse mammary tumor virus integration site (WNT)16 that were associated with peak BMD in premenopausal women. To further identify the role of Wnt16 in bone mass regulation, we created transgenic (TG) mice overexpressing human WNT16 in osteoblasts. We compared bone phenotypes, serum biochemistry, gene expression, and dynamic bone histomorphometry between TG and wild-type (WT) mice. Compared with WT mice, WNT16-TG mice exhibited significantly higher whole-body areal BMD and bone mineral content (BMC) at 6 and 12 weeks of age in both male and female. Microcomputer tomography analysis of trabecular bone at distal femur revealed 3-fold (male) and 14-fold (female) higher bone volume/tissue volume (BV/TV), and significantly higher trabecular number and trabecular thickness but lower trabecular separation in TG mice compared with WT littermates in both sexes. The cortical bone at femur midshaft also displayed significantly greater bone area/total area and cortical thickness in the TG mice in both sexes. Serum biochemistry analysis showed that male TG mice had higher serum alkaline phosphatase, osteocalcin, osteoprotegerin (OPG), OPG to receptor activator of NF-kB ligand (tumor necrosis family ligand superfamily, number 11; RANKL) ratio as compared with WT mice. Also, lower carboxy-terminal collagen cross-link (CTX) to tartrate-resistant acid phosphatase 5, isoform b (TRAPc5b) ratio was observed in TG mice compared with WT littermates in both male and female. Histomorphometry data demonstrated that both male and female TG mice had significantly higher cortical and trabecular mineralizing surface/bone surface and bone formation rate compared with sex-matched WT mice. Gene expression analysis demonstrated higher expression of Alp, OC, Opg, and Opg to Rankl ratio in bone tissue in the TG mice compared with WT littermates. Our data indicate that WNT16 is critical for positive regulation of both cortical and trabecular bone mass and structure and that this molecule might be targeted for therapeutic interventions to treat osteoporosis.

Original languageEnglish (US)
Pages (from-to)722-736
Number of pages15
JournalEndocrinology
Volume157
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Osteoblasts
Transgenic Mice
Bone and Bones
Bone Density
Osteoprotegerin
Biochemistry
Femur
Serum
Virus Integration
Ligands
Mouse mammary tumor virus
Gene Expression
Cortical Bone
Cancellous Bone
NF-kappa B
Genome-Wide Association Study
Osteocalcin
Microcomputers
Osteogenesis
Osteoporosis

ASJC Scopus subject areas

  • Endocrinology

Cite this

Osteoblast-specific overexpression of human WNT16 increases both cortical and trabecular bone mass and structure in mice. / Alam, Imranul; Alkhouli, Mohammed; Gerard-O'Riley, Rita L.; Wright, Weston B.; Acton, Dena; Gray, Amie K.; Patel, Bhavmik; Reilly, Austin M.; Lim, Kyung Eun; Robling, Alexander; Econs, Michael.

In: Endocrinology, Vol. 157, No. 2, 01.02.2016, p. 722-736.

Research output: Contribution to journalArticle

Alam, I, Alkhouli, M, Gerard-O'Riley, RL, Wright, WB, Acton, D, Gray, AK, Patel, B, Reilly, AM, Lim, KE, Robling, A & Econs, M 2016, 'Osteoblast-specific overexpression of human WNT16 increases both cortical and trabecular bone mass and structure in mice', Endocrinology, vol. 157, no. 2, pp. 722-736. https://doi.org/10.1210/en.2015-1281
Alam, Imranul ; Alkhouli, Mohammed ; Gerard-O'Riley, Rita L. ; Wright, Weston B. ; Acton, Dena ; Gray, Amie K. ; Patel, Bhavmik ; Reilly, Austin M. ; Lim, Kyung Eun ; Robling, Alexander ; Econs, Michael. / Osteoblast-specific overexpression of human WNT16 increases both cortical and trabecular bone mass and structure in mice. In: Endocrinology. 2016 ; Vol. 157, No. 2. pp. 722-736.
@article{c797c8cbc7ab45bfa1076b2e8e36e83e,
title = "Osteoblast-specific overexpression of human WNT16 increases both cortical and trabecular bone mass and structure in mice",
abstract = "Previous genome-wide association studies have identified common variants in genes associated with bone mineral density (BMD) and risk of fracture. Recently, we identified single nucleotide polymorphisms (SNPs) in Wingless-type mouse mammary tumor virus integration site (WNT)16 that were associated with peak BMD in premenopausal women. To further identify the role of Wnt16 in bone mass regulation, we created transgenic (TG) mice overexpressing human WNT16 in osteoblasts. We compared bone phenotypes, serum biochemistry, gene expression, and dynamic bone histomorphometry between TG and wild-type (WT) mice. Compared with WT mice, WNT16-TG mice exhibited significantly higher whole-body areal BMD and bone mineral content (BMC) at 6 and 12 weeks of age in both male and female. Microcomputer tomography analysis of trabecular bone at distal femur revealed 3-fold (male) and 14-fold (female) higher bone volume/tissue volume (BV/TV), and significantly higher trabecular number and trabecular thickness but lower trabecular separation in TG mice compared with WT littermates in both sexes. The cortical bone at femur midshaft also displayed significantly greater bone area/total area and cortical thickness in the TG mice in both sexes. Serum biochemistry analysis showed that male TG mice had higher serum alkaline phosphatase, osteocalcin, osteoprotegerin (OPG), OPG to receptor activator of NF-kB ligand (tumor necrosis family ligand superfamily, number 11; RANKL) ratio as compared with WT mice. Also, lower carboxy-terminal collagen cross-link (CTX) to tartrate-resistant acid phosphatase 5, isoform b (TRAPc5b) ratio was observed in TG mice compared with WT littermates in both male and female. Histomorphometry data demonstrated that both male and female TG mice had significantly higher cortical and trabecular mineralizing surface/bone surface and bone formation rate compared with sex-matched WT mice. Gene expression analysis demonstrated higher expression of Alp, OC, Opg, and Opg to Rankl ratio in bone tissue in the TG mice compared with WT littermates. Our data indicate that WNT16 is critical for positive regulation of both cortical and trabecular bone mass and structure and that this molecule might be targeted for therapeutic interventions to treat osteoporosis.",
author = "Imranul Alam and Mohammed Alkhouli and Gerard-O'Riley, {Rita L.} and Wright, {Weston B.} and Dena Acton and Gray, {Amie K.} and Bhavmik Patel and Reilly, {Austin M.} and Lim, {Kyung Eun} and Alexander Robling and Michael Econs",
year = "2016",
month = "2",
day = "1",
doi = "10.1210/en.2015-1281",
language = "English (US)",
volume = "157",
pages = "722--736",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Osteoblast-specific overexpression of human WNT16 increases both cortical and trabecular bone mass and structure in mice

AU - Alam, Imranul

AU - Alkhouli, Mohammed

AU - Gerard-O'Riley, Rita L.

AU - Wright, Weston B.

AU - Acton, Dena

AU - Gray, Amie K.

AU - Patel, Bhavmik

AU - Reilly, Austin M.

AU - Lim, Kyung Eun

AU - Robling, Alexander

AU - Econs, Michael

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Previous genome-wide association studies have identified common variants in genes associated with bone mineral density (BMD) and risk of fracture. Recently, we identified single nucleotide polymorphisms (SNPs) in Wingless-type mouse mammary tumor virus integration site (WNT)16 that were associated with peak BMD in premenopausal women. To further identify the role of Wnt16 in bone mass regulation, we created transgenic (TG) mice overexpressing human WNT16 in osteoblasts. We compared bone phenotypes, serum biochemistry, gene expression, and dynamic bone histomorphometry between TG and wild-type (WT) mice. Compared with WT mice, WNT16-TG mice exhibited significantly higher whole-body areal BMD and bone mineral content (BMC) at 6 and 12 weeks of age in both male and female. Microcomputer tomography analysis of trabecular bone at distal femur revealed 3-fold (male) and 14-fold (female) higher bone volume/tissue volume (BV/TV), and significantly higher trabecular number and trabecular thickness but lower trabecular separation in TG mice compared with WT littermates in both sexes. The cortical bone at femur midshaft also displayed significantly greater bone area/total area and cortical thickness in the TG mice in both sexes. Serum biochemistry analysis showed that male TG mice had higher serum alkaline phosphatase, osteocalcin, osteoprotegerin (OPG), OPG to receptor activator of NF-kB ligand (tumor necrosis family ligand superfamily, number 11; RANKL) ratio as compared with WT mice. Also, lower carboxy-terminal collagen cross-link (CTX) to tartrate-resistant acid phosphatase 5, isoform b (TRAPc5b) ratio was observed in TG mice compared with WT littermates in both male and female. Histomorphometry data demonstrated that both male and female TG mice had significantly higher cortical and trabecular mineralizing surface/bone surface and bone formation rate compared with sex-matched WT mice. Gene expression analysis demonstrated higher expression of Alp, OC, Opg, and Opg to Rankl ratio in bone tissue in the TG mice compared with WT littermates. Our data indicate that WNT16 is critical for positive regulation of both cortical and trabecular bone mass and structure and that this molecule might be targeted for therapeutic interventions to treat osteoporosis.

AB - Previous genome-wide association studies have identified common variants in genes associated with bone mineral density (BMD) and risk of fracture. Recently, we identified single nucleotide polymorphisms (SNPs) in Wingless-type mouse mammary tumor virus integration site (WNT)16 that were associated with peak BMD in premenopausal women. To further identify the role of Wnt16 in bone mass regulation, we created transgenic (TG) mice overexpressing human WNT16 in osteoblasts. We compared bone phenotypes, serum biochemistry, gene expression, and dynamic bone histomorphometry between TG and wild-type (WT) mice. Compared with WT mice, WNT16-TG mice exhibited significantly higher whole-body areal BMD and bone mineral content (BMC) at 6 and 12 weeks of age in both male and female. Microcomputer tomography analysis of trabecular bone at distal femur revealed 3-fold (male) and 14-fold (female) higher bone volume/tissue volume (BV/TV), and significantly higher trabecular number and trabecular thickness but lower trabecular separation in TG mice compared with WT littermates in both sexes. The cortical bone at femur midshaft also displayed significantly greater bone area/total area and cortical thickness in the TG mice in both sexes. Serum biochemistry analysis showed that male TG mice had higher serum alkaline phosphatase, osteocalcin, osteoprotegerin (OPG), OPG to receptor activator of NF-kB ligand (tumor necrosis family ligand superfamily, number 11; RANKL) ratio as compared with WT mice. Also, lower carboxy-terminal collagen cross-link (CTX) to tartrate-resistant acid phosphatase 5, isoform b (TRAPc5b) ratio was observed in TG mice compared with WT littermates in both male and female. Histomorphometry data demonstrated that both male and female TG mice had significantly higher cortical and trabecular mineralizing surface/bone surface and bone formation rate compared with sex-matched WT mice. Gene expression analysis demonstrated higher expression of Alp, OC, Opg, and Opg to Rankl ratio in bone tissue in the TG mice compared with WT littermates. Our data indicate that WNT16 is critical for positive regulation of both cortical and trabecular bone mass and structure and that this molecule might be targeted for therapeutic interventions to treat osteoporosis.

UR - http://www.scopus.com/inward/record.url?scp=84956916539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956916539&partnerID=8YFLogxK

U2 - 10.1210/en.2015-1281

DO - 10.1210/en.2015-1281

M3 - Article

C2 - 26584014

AN - SCOPUS:84956916539

VL - 157

SP - 722

EP - 736

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 2

ER -